Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mitomycin 2mg powder for solution for injection vials
0801020Q0AAAEAE
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin 40mg powder for intravesical solution vials
0801020Q0AAADAD
|
Mitomycin | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 10mg inj vials
0801020Q0BBABAF
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 20mg inj vials
0801020Q0BBACAG
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 2mg inj vials
0801020Q0BBAAAE
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitomycin-C Kyowa 40mg pdr for intravesical solution vials
0801020Q0BBADAD
|
Mitomycin-C Kyowa | Mitomycin | Malignant Disease and Immunosuppression | No data available |
|
Mitoxana 1g powder for solution for injection vials
0801010N0BBABAB
|
Mitoxana | Ifosfamide | Malignant Disease and Immunosuppression | No data available |
|
Mitoxana 2g powder for solution for injection vials
0801010N0BBACAC
|
Mitoxana | Ifosfamide | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 10mg/5ml solution for infusion vials
0801020R0AAAEAE
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 20mg/10ml solution for infusion vials
0801020R0AAAAAA
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 25mg/12.5ml solution for infusion vials
0801020R0AAABAB
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mitoxantrone 30mg/15ml solution for infusion vials
0801020R0AAACAC
|
Mitoxantrone | Mitoxantrone | Malignant Disease and Immunosuppression | No data available |
|
Mycophenolate mofetil 100mg/5ml oral suspension
0802010M0AAAGAG
|
Mycophenolate mofetil (Systemic) | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Mycophenolate mofetil 125mg/5ml oral suspension
0802010M0AAAIAI
|
Mycophenolate mofetil (Systemic) | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Mycophenolate mofetil 250mg/5ml oral suspension
0802010M0AAACAC
|
Mycophenolate mofetil (Systemic) | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Mycophenolate mofetil 300mg/5ml oral suspension
0802010M0AAADAD
|
Mycophenolate mofetil (Systemic) | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Mycophenolate mofetil 500mg inf vials
0802010M0AAAHAH
|
Mycophenolate mofetil (Systemic) | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Mycophenolate mofetil 500mg/5ml oral suspension
0802010M0AAAEAE
|
Mycophenolate mofetil (Systemic) | Mycophenolate mofetil | Malignant Disease and Immunosuppression | No data available |
|
Myleran 2mg tablets
0801010B0BBABAB
|
Myleran | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Myocet 50mg inf vials
0801020K0BEAAAH
|
Myocet | Doxorubicin hydrochloride | Malignant Disease and Immunosuppression | No data available |
|
Nastrosa 1mg tablets
0803041B0BCAAAA
|
Nastrosa | Anastrozole | Malignant Disease and Immunosuppression | No data available |
|
Natalizumab 300mg/15ml solution for infusion vials
0802040W0AAAAAA
|
Natalizumab | Natalizumab | Malignant Disease and Immunosuppression | No data available |
|
Navelbine 10mg/1ml concentrate for inf vials
0801040R0BBAAAA
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Navelbine 20mg capsules
0801040R0BBACAC
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
|
Navelbine 30mg capsules
0801040R0BBADAD
|
Navelbine | Vinorelbine | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.